Inventor · disambiguated record
Kedarnath Sastry
Also filed as: SASTRY KEDARNATH · SASTRY KEDARNATH N · SASTRY KEDARNATH NANJUND
19 granted patents·3 pending applications·118 citations·filing 2007–2025
95Inventor score
Top patents by PatentIndex Score
22 records- 0195US8815247B2Targeted/immunomodulatory fusion proteinsBIOCON LTD·Filed 2013·Granted Aug 26, 2014·27 cites·1 claims
- 0292US9758582B2Anti-CTLA4 antibody-TGF-βRII targeted/immunomodulatory fusion proteinsBIOCON LTD·Filed 2016·Granted Sep 12, 2017·8 cites·1 claims
- 0391US12049632B2Anti-EGFR1-PD1 targeted/immunomodulatory fusion proteinBIOCON LTD·Filed 2021·Granted Jul 30, 2024·1 cites·3 claims
- 0491US2025011794A1Targeted/immunomodulatory fusion proteins and methods for making sameBIOCON LTD·Filed 2024·Application pending·0 cites
- 0590US9670285B2Monoclonal antibody and a method thereofBIOCON LTD·Filed 2015·Granted Jun 6, 2017·7 cites·4 claims
- 0689US11028399B2CTLA4/PD1 targeted/immunomodulatory fusion proteinsBIOCON LTD·Filed 2019·Granted Jun 8, 2021·2 cites·2 claims
- 0789US10669346B2Monoclonal antibody and a method thereofBIOCON LTD·Filed 2018·Granted Jun 2, 2020·2 cites·12 claims
- 0889US10000573B2Monoclonal antibody and a method thereofBIOCON LTD·Filed 2017·Granted Jun 19, 2018·6 cites·9 claims
- 0989US8524233B2Monoclonal antibody and a method thereofMELARKODE RAMAKRISHNAN·Filed 2008·Granted Sep 3, 2013·14 cites·6 claims
- 1088US9217037B2Monoclonal antibody and a method thereofBIOCON LTD·Filed 2013·Granted Dec 22, 2015·8 cites·2 claims
- 1187US2024417483A1Monoclonal antibody and a method thereofBIOCON LTD·Filed 2024·Application pending·0 cites
- 1285US11981743B2Monoclonal antibody and a method thereofBIOCON LTD·Filed 2020·Granted May 14, 2024·1 cites·11 claims
- 1385US8778659B2Method of reducing glycosylation of proteins, processes and proteins thereofGOVINDAPPA NAGARAJ·Filed 2010·Granted Jul 15, 2014·10 cites·18 claims
- 1485US8114632B2Method of producing biologically active polypeptide having insulinotropic activityMELARKODE RAMAKRISHNAN·Filed 2007·Granted Feb 14, 2012·15 cites·14 claims
- 1583US10385348B2Epidermal growth factor receptor targeted/immunomodulatory fusion proteins and methods of use for themBIOCON LTD·Filed 2017·Granted Aug 20, 2019·2 cites·8 claims
- 1683US10144934B2Targeted/TGF-ßRII fusion proteins and methods for making sameBIOCON LTD·Filed 2017·Granted Dec 4, 2018·2 cites·14 claims
- 1783US8975041B2Fusion proteins and method of expression thereofGOVINDAPPA NAGARAJ·Filed 2009·Granted Mar 10, 2015·9 cites·9 claims
- 1883US2025368743A1Fusion immunomodulatory proteins and methods for making sameBIOCON LTD·Filed 2025·Application pending·0 cites
- 1982US9809651B2Method of treating cancer with an EGFR targeted immunomodulatory fusion proteinBIOCON LTD·Filed 2016·Granted Nov 7, 2017·2 cites·6 claims
- 2080US9340617B2Targeted/immunomodulatory fusion proteins and methods for making sameBIOCON LTD·Filed 2014·Granted May 17, 2016·2 cites·1 claims
- 2174US12351636B2Fusion immunomodulatory proteins and methods for making sameBIOCON LTD·Filed 2020·Granted Jul 8, 2025·0 cites·2 claims
- 2238US9090705B2Process for preparation of insulin compoundsHAZRA PARTHA·Filed 2008·Granted Jul 28, 2015·0 cites·15 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →